Susceptibility of <i>Neisseria gonorrhoeae</i> to azithromycin and ceftriaxone in…

The following two tabs change content below.
PLoS Medicine

PLoS Medicine

PLOS (The Public Library of Science) is a non profit publisher and advocacy organization on a mission to lead a transformation in research communication. From its start, PLOS has engaged in debate about science and medicine. Content from PLoS is shared via RSS through GHHub using the Creative Commons. http://www.plosmedicine.org/

by Yue-Ping Yin, Yan Han, Xiu-Qin Dai, He-Ping Zheng, Shao-Chun Chen, Bang-Yong Zhu, Gang Yong, Na Zhong, Li-Hua Hu, Wen-Ling Cao, Zhong-Jie Zheng, Feng Wang, Qi Zhi, Xiao-Yu Zhu, Xiang-Sheng Chen Background Gonorrhea remains one of the most common sexually transmitted diseases worldwide. Successful treatment has been hampered by emerging resistance to each of the antibiotics recommended as first-line therapies. We retrospectively analyzed the susceptibility of gonorrhea to azithromycin and ceftriaxone using data from the China Gonococcal Resistance Surveillance Programme (China-GRSP) in order to provide evidence for updating the treatment recommendations in China. Methods and findings In this study, we included 3,849 isolates collected from patients with a confirmed positive Neisseria gonorrhoeae (N. gonorrhoeae) culture at clinic visits during the period of 1 January 2013 through 31 December 2016 in 7 provinces.

More:

Susceptibility of <i>Neisseria gonorrhoeae</i> to azithromycin and ceftriaxone in…